Trial Site Detail

 

Drug:
Imatinib
Trial:
Five Year Adjuvant Imatinib Mesylate (GleevecĀ®) in Gastrointestinal Stromal Tumor (GIST) (Novartis CSTI571BUS282)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Cedars-Sinai Outpatient Cancer Center

8700 Beverly Blvd.     
Los Angeles , CA 90048
USA

 

Principal Investigator:
Charles Forscher, MD
Contact:
Mimi Lee 310-248-6688
Activation Status of this Site:
Closed
Notes about this Site:
Cedars-Sinai Outpatient Cancer Center Website:
http://apps.csmc.edu/SearchClinicalTrials/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.